An emerging market is a country that has some characteristics of a developed market, but does not meet standards to be a developed market. This includes countries that may become developed markets in the future or were in the past. The term "frontier market" is used for developing countries with slower economies than "emerging". The economies of China and India are considered to be the largest. The four largest emerging and developing economies by either nominal or PPP-adjusted GDP are the BRIC countries (Brazil, Russia, India and China). The next five largest markets are South Korea, Mexico, Indonesia, Turkey, and Saudi Arabia. Iran is also considered an emerging market.
Saturday, March 26, 2016
Friday, March 18, 2016
Promoter
A promoter is an individual or company that, for a fee, helps raise money for some type of investment activity. Most often, promoters raise money for a company through offering investment vehicles other than traditional stocks and bonds, such as limited partnerships and direct investment activities. Often times, these promoters are paid in company stock or free entrance into the investment activity as compensation for their work in raising funds from others.
Tuesday, February 9, 2016
LUPIN LTD.
Lupin Ltd., incorporated in the year 1983, is a Large Cap company operating in Pharmaceuticals and
health care sector. It's key Products Segments include Tablets which contributed 48.94% of Total Sales), Capsules which contributed 17.86% of Total Sales, Bulk Drugs which contributed 11.74% of Total Sales), Liquids which contributed 7.59% of Total Sales, Injectible Vials which contributed 5.38% of Total Sales, other Services which contributed 3.82% of Total Sales, for the year ending 31-Mar-2015.
The company’s management includes Dr.Desh Bandhu Gupta, Dr.K U Mada, Dr.Kamal K Sharma, Dr.Vijay Kelkar, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Gupta, Mr.R A Shah, Mr.Ramesh Swaminathan, Mr.Richard Zahn, Mrs.M D Gupta, Ms.Vinita Gupta, Dr.Cyrus Karkaria, Dr.Maurice Chagnaud, Dr.Rajender Kamboj, Dr.Sofia Mumtaz, Mr.Alok Ghosh, Mr.Alpesh Dalal, Mr.Debabrata Chakravorty, Mr.Divakar Kaza, Mr.Naresh Gupta, Mr.Pradeep Bhagwat, Mr.R V Satam, Mr.Shakti Chakraborty, Mr.Shamsher Gorawara, Mr.Sunil Makharia, Mr.Thierry Volle, Mr.Vinod Dhawan.
health care sector. It's key Products Segments include Tablets which contributed 48.94% of Total Sales), Capsules which contributed 17.86% of Total Sales, Bulk Drugs which contributed 11.74% of Total Sales), Liquids which contributed 7.59% of Total Sales, Injectible Vials which contributed 5.38% of Total Sales, other Services which contributed 3.82% of Total Sales, for the year ending 31-Mar-2015.
The company’s management includes Dr.Desh Bandhu Gupta, Dr.K U Mada, Dr.Kamal K Sharma, Dr.Vijay Kelkar, Mr.Dileep C Choksi, Mr.Jean-Luc Belingard, Mr.Nilesh Gupta, Mr.R A Shah, Mr.Ramesh Swaminathan, Mr.Richard Zahn, Mrs.M D Gupta, Ms.Vinita Gupta, Dr.Cyrus Karkaria, Dr.Maurice Chagnaud, Dr.Rajender Kamboj, Dr.Sofia Mumtaz, Mr.Alok Ghosh, Mr.Alpesh Dalal, Mr.Debabrata Chakravorty, Mr.Divakar Kaza, Mr.Naresh Gupta, Mr.Pradeep Bhagwat, Mr.R V Satam, Mr.Shakti Chakraborty, Mr.Shamsher Gorawara, Mr.Sunil Makharia, Mr.Thierry Volle, Mr.Vinod Dhawan.
Thursday, January 21, 2016
MAX India Ltd
"Max India Ltd is demerging its health & allied business and
specialty film business into Taurus Ventures Ltd and Capricorn Ventures
Ltd, respectively. Effective at the open of Wednesday, January 27, 2016,
Max India will be dropped from the indices," BSE said in a circular
issued on Thursday.
In all, Max India will be excluded from seven indices, including S&P BSE 200, S&P BSE 500, S&P BSE AllCap and S&P BSE Industrials.
Kansai Nerolac Paints and Syngene International will fill its slot in BSE 200 and BSE 500, respectively.
In all, Max India will be excluded from seven indices, including S&P BSE 200, S&P BSE 500, S&P BSE AllCap and S&P BSE Industrials.
Kansai Nerolac Paints and Syngene International will fill its slot in BSE 200 and BSE 500, respectively.
Subscribe to:
Posts (Atom)